The F.D.A.’s Approval of Biogen’s Alzheimer’s Drug Is a New Low June 16, 2021 Auto Bot Aduhelm (Drug), alzheimer's disease, Biogen Inc, Food and Drug Administration 0 The F.D.A.’s approval of the Alzheimer’s drug aducanumab is inexplicable.